Florian Deuschl* Niklas Schofer* Edith Lubos, Stefan Blankenberg, Ulrich Schäfer Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany *These authors contributed equally to this work Abstract: The MitraClip (MC) system is a device for percutaneous, transseptal edge-to-edge reconstruction of the mitral valve (MV) in patients with severe mitral regurgitation (MR) not eligible for surgery. Recently, a number of studies have underlined the therapeutic benefit of the MC system for patients with extreme and high risk for MV surgery suffering from either degenerative or functional MR. The MC procedure shows negligible intraprocedural mortality, low periprocedural complication rates, and...
Mitral regurgitation (MR) is a common valvulopathy worldwide increasing in prevalence. Cardiac surgi...
Patients with heart failure who have secondary severe mitral regurgitation due to left ventricular d...
Mitral regurgitation (MR) is the second most common heart valve disease worldwide and the current go...
J Trent Magruder,1 Todd C Crawford,1 Joshua C Grimm,1 Joseph L Fredi,2 Ashish S Shah3 1Division of C...
Background: Percutaneous edge-to-edge mitral valve repair with the MitraClip® was shown to be a safe...
Mitral regurgitation is the second most common valvular disease. The etiology is either primary or f...
Mitral regurgitation (MR) is the most common cardiac valvular disease in the United States. Approxim...
AbstractObjectivesTo evaluate the feasibility, efficacy, and safety of the MitraClip system in patie...
To evaluate the feasibility, efficacy, and safety of the MitraClip system in patients with severe MR...
Introduction: Symptomatic mitral regurgitation has poor prognosis without surgical treatment. This l...
Introduction. MitraClip (MC) is a catheter-based device to treat mitral regurgitation (MR). This met...
Mitral regurgitation (MR) is a common valvulopathy worldwide increasing in prevalence. Cardiac surgi...
Mitral regurgitation (MR) is a common valvulopathy worldwide increasing in prevalence. Cardiac surgi...
Mitral regurgitation (MR) is a common valvulopathy worldwide increasing in prevalence. Cardiac surgi...
Background MitraClip implantation has emerged as a viable option in high surgical risk patients with...
Mitral regurgitation (MR) is a common valvulopathy worldwide increasing in prevalence. Cardiac surgi...
Patients with heart failure who have secondary severe mitral regurgitation due to left ventricular d...
Mitral regurgitation (MR) is the second most common heart valve disease worldwide and the current go...
J Trent Magruder,1 Todd C Crawford,1 Joshua C Grimm,1 Joseph L Fredi,2 Ashish S Shah3 1Division of C...
Background: Percutaneous edge-to-edge mitral valve repair with the MitraClip® was shown to be a safe...
Mitral regurgitation is the second most common valvular disease. The etiology is either primary or f...
Mitral regurgitation (MR) is the most common cardiac valvular disease in the United States. Approxim...
AbstractObjectivesTo evaluate the feasibility, efficacy, and safety of the MitraClip system in patie...
To evaluate the feasibility, efficacy, and safety of the MitraClip system in patients with severe MR...
Introduction: Symptomatic mitral regurgitation has poor prognosis without surgical treatment. This l...
Introduction. MitraClip (MC) is a catheter-based device to treat mitral regurgitation (MR). This met...
Mitral regurgitation (MR) is a common valvulopathy worldwide increasing in prevalence. Cardiac surgi...
Mitral regurgitation (MR) is a common valvulopathy worldwide increasing in prevalence. Cardiac surgi...
Mitral regurgitation (MR) is a common valvulopathy worldwide increasing in prevalence. Cardiac surgi...
Background MitraClip implantation has emerged as a viable option in high surgical risk patients with...
Mitral regurgitation (MR) is a common valvulopathy worldwide increasing in prevalence. Cardiac surgi...
Patients with heart failure who have secondary severe mitral regurgitation due to left ventricular d...
Mitral regurgitation (MR) is the second most common heart valve disease worldwide and the current go...